Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor

High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.

Bone marrow transplantation·2017

Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

Cancer chemotherapy and pharmacology·2017

Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.

Bone marrow transplantation·2014

Leukemic stem cells: a review.

Cancer investigation·2013

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.

Bone marrow transplantation·2013

MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia.

Leukemia·2012

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Proton Pump Inhibitor Use Was Not Associated With Reduced Gastrointestinal Bleeding Risk in Ischemic Stroke Patients Treated With Dual Antiplatelet Therapy.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026

Aneurysmal subarachnoid hemorrhage: predictive score for angiographic vasospasm.

Arquivos de neuro-psiquiatria·2026

Platelet GPVI drives fibrotic lung remodeling.

Blood advances·2026

Blood clot contraction depends on spatial distribution of fibrin, red blood cells and platelets.

Journal of the mechanical behavior of biomedical materials·2026

Temporal morphological differentiation of menstrual and peripheral bloodstains on a semi-porous substrate: A controlled stereo-microscopic study.

Journal of forensic and legal medicine·2026

Interventional Management of Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: Are There Differences Between East and West?

Current oncology reports·2026

Related Experiment Videos

Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor

Related Concept Videos

High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.

Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.

Leukemic stem cells: a review.

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment.

MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Proton Pump Inhibitor Use Was Not Associated With Reduced Gastrointestinal Bleeding Risk in Ischemic Stroke Patients Treated With Dual Antiplatelet Therapy.

Aneurysmal subarachnoid hemorrhage: predictive score for angiographic vasospasm.

Platelet GPVI drives fibrotic lung remodeling.

Blood clot contraction depends on spatial distribution of fibrin, red blood cells and platelets.

Temporal morphological differentiation of menstrual and peripheral bloodstains on a semi-porous substrate: A controlled stereo-microscopic study.

Interventional Management of Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: Are There Differences Between East and West?

Related Experiment Videos

Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor

Related Concept Videos

Related Articles